We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA’s warning letters for 2019 once again targeted many familiar GMP failures, such as quality units that either lacked or failed to follow written procedures. Read More
2019 was one of the biggest years on record for pharma mergers and acquisitions, including the third largest acquisition of all time — Bristol-Myers Squibb’s $74 billion acquisition of Celgene. Read More
Michigan’s attorney general has filed suit against four major drug distributors for their alleged role in the opioid crisis — invoking for the first time a law that allows the state to pursue drug dealers for civil damages. Read More
President Trump signed a fiscal 2020 federal budget package into law Friday that increases funding for the FDA for the third time in three years. Read More
In observance of the holiday season, Drug Industry Daily will not be published Tuesday, Dec. 24 or Wednesday, Dec. 25. The next issue will be published Thursday, Dec. 26. Read More